| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. | Proc Natl Acad Sci U S A | 2004 | 1.85 |
| 2 | Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. | J Immunol | 2008 | 1.57 |
| 3 | Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses. | Biol Blood Marrow Transplant | 2008 | 1.07 |
| 4 | Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. | Blood | 2011 | 1.01 |
| 5 | Hematopoietic progenitor cell regulation by CD4+CD25+ T cells. | Blood | 2010 | 0.90 |